These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 28820321

  • 1. Non-Surgical Therapy Reduces Presence of JP2 Clone in Localized Aggressive Periodontitis.
    Burgess DK, Huang H, Harrison P, Kompotiati T, Aukhil I, Shaddox LM.
    J Periodontol; 2017 Dec; 88(12):1263-1270. PubMed ID: 28820321
    [Abstract] [Full Text] [Related]

  • 2. Effect of periodontal treatment on Aggregatibacter actinomycetemcomitans colonization and serum IgG levels against A. actinomycetemcomitans serotypes and Omp29 of aggressive periodontitis patients.
    Rebeis ES, Albuquerque-Souza E, Paulino da Silva M, Giudicissi M, Mayer MPA, Saraiva L.
    Oral Dis; 2019 Mar; 25(2):569-579. PubMed ID: 30506613
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans in localized and generalized forms of aggressive periodontitis.
    Ennibi OK, Benrachadi L, Bouziane A, Haubek D, Poulsen K.
    Acta Odontol Scand; 2012 Jul; 70(4):318-22. PubMed ID: 22251014
    [Abstract] [Full Text] [Related]

  • 7. High salivary levels of JP2 genotype of Aggregatibacter actinomycetemcomitans is associated with clinical attachment loss in Moroccan adolescents.
    Ennibi OK, Claesson R, Akkaoui S, Reddahi S, Kwamin F, Haubek D, Johansson A.
    Clin Exp Dent Res; 2019 Feb; 5(1):44-51. PubMed ID: 30847232
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical and microbiologic evaluation, by real-time polymerase chain reaction, of non-surgical treatment of aggressive periodontitis associated with amoxicillin and metronidazole.
    Rodrigues AS, Lourenção DS, Lima Neto LG, Pannuti CM, Hirata RD, Hirata MH, Lotufo RF, De Micheli G.
    J Periodontol; 2012 Jun; 83(6):744-52. PubMed ID: 22060046
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans: evolutionary aspects, epidemiology and etiological role in aggressive periodontitis.
    Haubek D.
    APMIS Suppl; 2010 Sep; (130):1-53. PubMed ID: 21214629
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduction in prevalence of Archaea after periodontal therapy in subjects with generalized aggressive periodontitis.
    Lira EA, Ramiro FS, Chiarelli FM, Dias RR, Feres M, Figueiredo LC, Faveri M.
    Aust Dent J; 2013 Dec; 58(4):442-7. PubMed ID: 24320900
    [Abstract] [Full Text] [Related]

  • 18. Microbiologic Response to Periodontal Therapy and Multivariable Prediction of Clinical Outcome.
    Mombelli A, Almaghlouth A, Cionca N, Cancela J, Courvoisier DS, Giannopoulou C.
    J Periodontol; 2017 Dec; 88(12):1253-1262. PubMed ID: 28844191
    [Abstract] [Full Text] [Related]

  • 19. Systemic administration of doxycycline versus metronidazole plus amoxicillin in the treatment of localized aggressive periodontitis: a clinical and microbiologic study.
    Akincibay H, Orsal SO, Sengün D, Tözüm TF.
    Quintessence Int; 2008 Feb; 39(2):e33-9. PubMed ID: 18567166
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.